Video: Cromos Pharma and Avance Clinical Collaboration

08 October 2020

Cromos Pharma and Avance Clinical with operations in Europe and Australia, respectively, are successfully collaborating on a scalable clinical solution for biotechs. 


The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access the large patient populations for their Phase 2 and 3 studies.

Importantly, the AU/EU model allows biotechs to keep their data and trial management in Australia, and take advantage of the Australian cash rebate of up to 43.5% on clinical trial costs, throughout all study phases, across both regions.

Email: inquiry@cromospharma.com

Back to the news